Skip to main content
Volkan Granit, MD, Neurology, Miami, FL

VolkanGranitMDMSc

Neurology Miami, FL

Neuromuscular Medicine

Medical Director, Clinical Development, Biohaven Pharmaceuticals. Voluntary Associate Professor, University Of Miami Department of Neurology, Neuromuscular Division

Dr. Granit is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Granit's full profile

Already have an account?

  • Office

    1150 NW 14th St
    Ste 410
    Miami, FL 33136
    Phone+1 305-243-3100
    Fax+1 305-243-8108

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineFellowship, EMG, Neurmuscular Disorders, 2012 - 2013
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 2012
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 2008 - 2009
  • Albert Einstein College of Medicine, Sue Golding G
    Albert Einstein College of Medicine, Sue Golding GMS, Neuroscienece, 2004 - 2008
  • Istanbul University Fom
    Istanbul University FomClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2025
  • NY State Medical License
    NY State Medical License 2012 - 2019
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Electrodiagnostic MedicineElectrodiagnostic Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Cartesian Therapeutics to Present Late-Breaking Data from Phase 1/2a Trial of RNA CAR T-cell Therapy in Patients with Generalized Myasthenia Gravis
    Cartesian Therapeutics to Present Late-Breaking Data from Phase 1/2a Trial of RNA CAR T-cell Therapy in Patients with Generalized Myasthenia GravisMay 10th, 2022
  • ALS Center at University of Miami Receives State Funding for Patient Care
    ALS Center at University of Miami Receives State Funding for Patient CareSeptember 25th, 2020
  • Cartesian Initiates CAR-T Clinical Trial in Myasthenia Gravis
    Cartesian Initiates CAR-T Clinical Trial in Myasthenia GravisNovember 5th, 2019

Other Languages

  • French, Turkish